Priscilla Duggan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Molecular Docking

Structural Basis

Top Venues

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature 630 (8015) (2024)
Audrey L Warren, David Lankri, Michael J Cunningham, Inis C Serrano, Lyonna F Parise, Andrew C Kruegel, Priscilla Duggan, Gregory Zilberg, Michael J Capper, Václav Havel, Scott J Russo, Dalibor Sames, Daniel Wacker
Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature (2024)
Michael J Cunningham, Hailey A Bock, Inis C Serrano, Benjamin Bechand, D J Vidyadhara, Emma M Bonniwell, David Lankri, Priscilla Duggan, Antonina L Nazarova, Andrew B Cao, Maggie M Calkins, Prashant Khirsariya, Christopher Hwu, Vsevolod Katritch, Sreeganga S Chandra, John D McCorvy, Dalibor Sames
Pharmacological Mechanism of the Non-hallucinogenic 5-HT 2A Agonist Ariadne and Analogs. ACS chemical neuroscience 14 (1) (2022)
Michael J Cunningham, Hailey A Bock, Inis C Serrano, Benjamin Bechand, D J Vidyadhara, Emma M Bonniwell, David Lankri, Priscilla Duggan, Antonina L Nazarova, Andrew B Cao, Maggie M Calkins, Prashant Khirsariya, Christopher Hwu, Vsevolod Katritch, Sreeganga S Chandra, John D McCorvy, Dalibor Sames
Pharmacological Mechanism of the Non-hallucinogenic 5-HT 2A Agonist Ariadne and Analogs. ACS chemical neuroscience 14 (1) (2022)
Michael J Cunningham, Hailey A Bock, Inis C Serrano, Benjamin Bechand, D J Vidyadhara, Emma M Bonniwell, David Lankri, Priscilla Duggan, Antonina L Nazarova, Andrew B Cao, Maggie M Calkins, Prashant Khirsariya, Christopher Hwu, Vsevolod Katritch, Sreeganga S Chandra, John D McCorvy, Dalibor Sames
Pharmacological Mechanism of the Non-hallucinogenic 5-HT 2A Agonist Ariadne and Analogs. ACS chemical neuroscience (2022)
Michael J Cunningham, Hailey A Bock, Inis C Serrano, Benjamin Bechand, D J Vidyadhara, Emma M Bonniwell, David Lankri, Priscilla Duggan, Antonina L Nazarova, Andrew B Cao, Maggie M Calkins, Prashant Khirsariya, Christopher Hwu, Vsevolod Katritch, Sreeganga S Chandra, John D McCorvy, Dalibor Sames
Pharmacological Mechanism of the Non-hallucinogenic 5-HT 2A Agonist Ariadne and Analogs. ACS chemical neuroscience 14 (1) (2022)